Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance

Go back to Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance
(NASDAQ: AVDL) Delayed: 21.64 --0 (-0%)
Previous Close $21.64    52 Week High
Open $21.64    52 Week Low
Day High $21.64    P/E N/A 
Day Low $21.64    EPS
Volume 55